{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T03:16:27Z","timestamp":1776914187817,"version":"3.51.2"},"reference-count":91,"publisher":"Hindawi Limited","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2375,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1111\/j.1742-1241.2008.01908.x","type":"journal-article","created":{"date-parts":[[2009,2,2]],"date-time":"2009-02-02T20:38:22Z","timestamp":1233607102000},"page":"468-477","source":"Crossref","is-referenced-by-count":13,"title":["Aspirin in cardiology - benefits and risks"],"prefix":"10.1155","volume":"63","author":[{"given":"L.","family":"Bj\u00f6rklund","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-A.","family":"Wallander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Les\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","reference":[{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB1","volume-title":"The World Health Report 2004 - Changing History","author":"World Health Organization","year":"2004"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/pgmj.2003.007062","article-title":"Antiplatelet therapy in cardiovascular disease","volume":"80","author":"Behan","year":"2004","journal-title":"Postgrad Med J"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1365-2796.2002.00947.x","article-title":"Preventing atherothrombotic events in peripheral arterial disease: the use of antiplatelet therapy","volume":"251","author":"Hiatt","year":"2002","journal-title":"J Intern Med"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ddr.430250402","article-title":"Mitogen-inducible prostaglandin G\/H synthase: a new target for nonsteroidal antiinflammatory drugs","volume":"25","author":"Xie","year":"1992","journal-title":"Drug Dev Res"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1185\/030079907X162656","article-title":"Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment","volume":"23","author":"Lanas","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB6","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1172\/JCI13271","article-title":"Why there are two cyclooxygenase isozymes","volume":"107","author":"Smith","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB7","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/BF00053030","article-title":"The case of low-dose aspirin for the prevention of myocardial infarction: but how low is low?","volume":"10","author":"Forster","year":"1997","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"Cyclooxygenases 1 and 2","volume":"38","author":"Vane","year":"1998","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB9","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1096\/fj.03-0645rev","article-title":"Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic","volume":"18","author":"Warner","year":"2004","journal-title":"FASEB J"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB10","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1053\/bega.2001.0233","article-title":"Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs","volume":"15","author":"McCarthy","year":"2001","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB11","first-page":"15","article-title":"COX-1 and COX-2 tissue expression: implications and predictions","volume":"49","author":"Crofford","year":"1997","journal-title":"J Rheumatol Suppl"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB12","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJMp048288","article-title":"Coxibs and cardiovascular disease","volume":"351","author":"Fitzgerald","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1378\/chest.87.3.386","article-title":"Aspirin-sensitive asthma","volume":"87","author":"Slepian","year":"1985","journal-title":"Chest"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1398-9995.1997.tb01039.x","article-title":"Mechanism of aspirin-induced asthma","volume":"52","author":"Szczeklik","year":"1997","journal-title":"Allergy"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5694\/j.1326-5377.2003.tb05474.x","article-title":"Aspirin for cardiovascular disease prevention","volume":"179","author":"Hung","year":"2003","journal-title":"Med J Aust"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Baigent","year":"2002","journal-title":"BMJ"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists\u2019 Collaboration","volume":"308","author":"Altman","year":"1994","journal-title":"BMJ"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB18","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa050613","article-title":"A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB19","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.CIR.101.10.1206","article-title":"Aspirin","volume":"101","author":"Awtry","year":"2000","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2174\/1568016054368188","article-title":"Aspirin and clopidogrel: a sweeping combination in cardiology","volume":"3","author":"Manolis","year":"2005","journal-title":"Curr Med Chem Cardiovasc Hematol Agents"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB21","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/archneur.57.3.326","article-title":"Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses","volume":"57","author":"Hart","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB22","first-page":"2379","article-title":"Stroke: strategies for primary prevention","volume":"68","author":"Ezekowitz","year":"2003","journal-title":"Am Fam Physician"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB23","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/bmj.38456.676806.8F","article-title":"Epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged \u2265\u200370","volume":"330","author":"Nelson","year":"2005","journal-title":"BMJ"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/aje\/kwh005","article-title":"Risk of uncomplicated peptic ulcer among users of aspirin and non-aspirin non-steroidal anti-inflammatory drugs","volume":"159","author":"Garcia Rodriguez","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6904-1-1","article-title":"Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations","volume":"1","author":"de Abajo","year":"2001","journal-title":"BMC Clin Pharmacol"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB26","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1046\/j.1365-2036.2001.01016.x","article-title":"Helicobacter pylori infection as a risk factor for gastrointestinal symptoms in patients using aspirin to prevent ischaemic heart disease","volume":"15","author":"Laheij","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB27","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1001\/jama.288.11.1388","article-title":"New evidence for stroke prevention: scientific review","volume":"288","author":"Straus","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB28","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/00001573-200209000-00017","article-title":"Aspirin in the prophylaxis of coronary artery disease","volume":"17","author":"Mehta","year":"2002","journal-title":"Curr Opin Cardiol"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB29","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/01.CIR.100.13.1481","article-title":"Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology","volume":"100","author":"Grundy","year":"1999","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-136-2-200201150-00016","article-title":"Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force","volume":"136","author":"Hayden","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/gut.46.1.27","article-title":"Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs","volume":"46","author":"Weil","year":"2000","journal-title":"Gut"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2036.2000.00679.x","article-title":"Non-steroidal anti-inflammatory drugs, Helicobacter pylori and bleeding gastric ulcer","volume":"14","author":"Ng","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB33","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1047-2797(00)00040-5","article-title":"The effect of alcohol abuse on the risk of NSAID-related gastrointestinal events","volume":"10","author":"Neutel","year":"2000","journal-title":"Ann Epidemiol"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(94)91843-0","article-title":"Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs","volume":"343","author":"Garcia Rodriguez","year":"1994","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB35","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1111\/j.1572-0241.2000.02248.x","article-title":"Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin","volume":"95","author":"Sorensen","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB36","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/gut.2005.080754","article-title":"Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations","volume":"55","author":"Lanas","year":"2006","journal-title":"Gut"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB37","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archinte.165.7.784","article-title":"Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction","volume":"165","author":"Buresly","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB38","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.3748\/wjg.v12.i18.2923","article-title":"Incidence and predictors of upper gastrointestinal bleeding in patients receiving low-dose aspirin for secondary prevention of cardiovascular events in patients with coronary artery disease","volume":"12","author":"Ng","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB39","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/bmj.310.6983.827","article-title":"Prophylactic aspirin and risk of peptic ulcer bleeding","volume":"310","author":"Weil","year":"1995","journal-title":"BMJ"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB40","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.amjcard.2005.01.049","article-title":"Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials","volume":"95","author":"Serebruany","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0016-5085(99)70545-7","article-title":"Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans","volume":"117","author":"Cryer","year":"1999","journal-title":"Gastroenterology"},{"issue":"4 Suppl. 2","key":"10.1111\/j.1742-1241.2008.01908.x-BIB42","first-page":"A44","article-title":"Can aspirin be reintroduced with proton pump inhibitor infusion after endoscopic hemostasis? A double blinded randomized controlled trial","volume":"130","author":"Sung","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB43","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/gut.37.4.509","article-title":"Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin - analysis of gastrointestinal bleeding during the UK-TIA trial","volume":"37","author":"Slattery","year":"1995","journal-title":"Gut"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB44","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/0016-5085(93)90952-9","article-title":"Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs","volume":"105","author":"Henry","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB45","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/archinte.160.14.2093","article-title":"Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding\/perforation: an overview of epidemiologic studies published in the 1990s","volume":"160","author":"Hernandez-Diaz","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB46","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.1365-2125.2002.01636.x","article-title":"Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data","volume":"54","author":"Lewis","year":"2002","journal-title":"Br J Clin Pharmacol"},{"issue":"4 Suppl. 2","key":"10.1111\/j.1742-1241.2008.01908.x-BIB47","article-title":"Prevention of low-dose aspirin-associated gastroduodenal ulcers and upper gastrointestinal symptoms in patients receiving esomeprazole 20\u2003mg per day","volume":"130","author":"Yeomans","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB48","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa012877","article-title":"Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use","volume":"346","author":"Lai","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB49","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1517\/14740338.1.3.245","article-title":"Treatment and prevention of aspirin-induced gastroduodenal ulcers and gastrointestinal bleeding","volume":"1","author":"Lanas","year":"2002","journal-title":"Expert Opin Drug Saf"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB50","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2036.2000.00739.x","article-title":"Low-dose misoprostol for the prevention of low-dose aspirin-induced gastroduodenal injury","volume":"14","author":"Donnelly","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB51","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s10620-006-9429-1","article-title":"Does adding misoprostol to standard intravenous proton pump inhibitor protocol improve the outcome of aspirin\/NSAID-induced upper gastrointestinal bleeding?: a randomized prospective study","volume":"52","author":"Yilmaz","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB52","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB53","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/archinte.163.10.1145","article-title":"Aspirin and clopidogrel in acute coronary syndromes: therapeutic insights from the CURE study","volume":"163","author":"Jneid","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB54","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1053\/euhj.2002.3385","article-title":"Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"23","author":"Bertrand","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB55","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1161\/01.CIR.0000091201.39590.CB","article-title":"Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study","volume":"108","author":"Peters","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB56","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB57","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1046\/j.1365-2036.1999.00588.x","article-title":"Enteric coating of aspirin significantly decreases gastroduodenal mucosal lesions","volume":"13","author":"Dammann","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB58","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2125.1991.tb05616.x","article-title":"Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis","volume":"32","author":"Hawthorne","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB59","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(96)01254-8","article-title":"Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product","volume":"348","author":"Kelly","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB60","first-page":"S1","article-title":"European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts)","volume":"10","author":"De Backer","year":"2003","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB61","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.CIR.0000047041.66447.29","article-title":"ACC\/AHA 2002 guideline update for the management of patients with chronic stable angina - summary article: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina)","volume":"107","author":"Gibbons","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB62","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/01.CIR.0000134791.68010.FA","article-title":"ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction)","volume":"110","author":"Antman","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB63","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1161\/01.CIR.0000037106.76139.53","article-title":"ACC\/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction - 2002: summary article: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina)","volume":"106","author":"Braunwald","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB64","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/01.CIR.0000020190.45892.75","article-title":"AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee","volume":"106","author":"Pearson","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB65","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-136-2-200201150-00015","article-title":"Aspirin for the primary prevention of cardiovascular events: recommendation and rationale","volume":"136","author":"Berg","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB66","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.2146\/ajhp040599","article-title":"ASHP therapeutic position statement on the daily use of aspirin for preventing cardiovascular events","volume":"62","author":"Saseen","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB67","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s002280050446","article-title":"Trends of prescribing patterns for the secondary prevention of myocardial infarction over a 13-year period","volume":"54","author":"Martinez","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB68","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1001\/archinte.163.12.1430","article-title":"National and state trends in quality of care for acute myocardial infarction between 1994-1995 and 1998-1999: the medicare health care quality improvement program","volume":"163","author":"Burwen","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB69","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/S0735-1097(00)00996-7","article-title":"Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3","volume":"36","author":"Rogers","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB70","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0002-8703(03)00531-3","article-title":"Comparison of treatment and outcomes for patients with acute myocardial infarction in Minneapolis\/St. Paul, Minnesota, and Goteborg, Sweden","volume":"146","author":"Herlitz","year":"2003","journal-title":"Am Heart J"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB71","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/jama.281.7.627","article-title":"Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project","volume":"281","author":"O\u2019Connor","year":"1999","journal-title":"JAMA"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB72","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1503\/cmaj.060122","article-title":"Does sex affect how patients respond to ASA?","volume":"174","author":"Murray","year":"2006","journal-title":"CMAJ"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB73","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jama.295.3.306","article-title":"Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials","volume":"295","author":"Berger","year":"2006","journal-title":"JAMA"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB74","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1365-2036.2002.01197.x","article-title":"Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding","volume":"16","author":"Stack","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB75","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.321.7270.1183","article-title":"Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis","volume":"321","author":"Derry","year":"2000","journal-title":"BMJ"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB76","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJM199110313251801","article-title":"A comparison of two doses of aspirin (30\u2003mg vs. 283\u2003mg a day) in patients after a transient ischemic attack or minor ischemic stroke. The Dutch TIA Trial Study Group","volume":"325","author":"van Gijn","year":"1991","journal-title":"N Engl J Med"},{"issue":"3 Suppl. 3","key":"10.1111\/j.1742-1241.2008.01908.x-BIB77","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1212\/WNL.51.3_Suppl_3.S15","article-title":"Low-dose and high-dose acetylsalicylic acid, with and without dipyridamole: a review of clinical trial results","volume":"51","author":"Tijssen","year":"1998","journal-title":"Neurology"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB78","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/ageing\/31.1.37","article-title":"Age- and sex-related bias in the management of heart disease in a district general hospital","volume":"31","author":"Dudley","year":"2002","journal-title":"Age Ageing"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB79","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1067\/mhj.2001.117776","article-title":"Decade-long trends (1986 to 1997) in the medical treatment of patients with acute myocardial infarction: a community-wide perspective","volume":"142","author":"Spencer","year":"2001","journal-title":"Am Heart J"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB80","doi-asserted-by":"crossref","first-page":"292","DOI":"10.7326\/0003-4819-124-3-199602010-00002","article-title":"Aspirin for secondary prevention after acute myocardial infarction in the elderly: prescribed use and outcomes","volume":"124","author":"Krumholz","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB81","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1161\/01.STR.31.4.822","article-title":"Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation","volume":"31","author":"Gage","year":"2000","journal-title":"Stroke"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB82","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/01.CIR.101.10.1097","article-title":"Aspirin use is low among United States outpatients with coronary artery disease","volume":"101","author":"Stafford","year":"2000","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB83","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1046\/j.1365-2125.2003.01795.x","article-title":"Evidence for an age and gender bias in the secondary prevention of ischaemic heart disease in primary care","volume":"55","author":"Williams","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB84","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/pubmed\/fdg007","article-title":"Prevalence and management of coronary heart disease in primary care: population-based cross-sectional study using a disease register","volume":"25","author":"Carroll","year":"2003","journal-title":"J Public Health Med"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB85","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijcard.2004.07.015","article-title":"Treatment and short-term outcome in women and men with acute coronary syndromes","volume":"103","author":"Perers","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB86","first-page":"82","article-title":"The influence of multiple variables on the prevalence of aspirin prescribing in patients with known coronary artery disease","volume":"3","author":"Avelar","year":"2003","journal-title":"Heartdrug"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB87","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/bmj.322.7290.832","article-title":"Sex inequalities in ischaemic heart disease in general practice: cross sectional survey","volume":"322","author":"Hippisley-Cox","year":"2001","journal-title":"BMJ"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB88","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1136\/jech.54.12.912","article-title":"Sex differences in risk factors, treatment and mortality after acute myocardial infarction: an observational study","volume":"54","author":"Hanratty","year":"2000","journal-title":"J Epidemiol Community Health"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB89","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1001\/archinte.1997.00440430048006","article-title":"Treatment and outcomes of acute myocardial infarction among patients of cardiologists and generalist physicians","volume":"157","author":"Ayanian","year":"1997","journal-title":"Arch Intern Med"},{"issue":"Suppl. 1","key":"10.1111\/j.1742-1241.2008.01908.x-BIB90","article-title":"Prevalence and prediction of gastrointestinal events in patients receiving a combination of aspirin plus clopidogrel","volume":"132","author":"Chan","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1742-1241.2008.01908.x-BIB91","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa042087","article-title":"Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding","volume":"352","author":"Chan","year":"2005","journal-title":"N Engl J Med"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2008.01908.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2008.01908.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:08:31Z","timestamp":1643350111000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2008.01908.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2008.01908.x","relation":{},"ISSN":["1368-5031","1742-1241"],"issn-type":[{"value":"1368-5031","type":"print"},{"value":"1742-1241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}